Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 831-840 of 10623

Edit search filters
  1. Network Neuro-modulation for Mesial Temporal Lobe Epilepsy

    Rochester, MN

  2. The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction

    Rochester, MN

  3. Workers Performance and Health Outcomes of Office Air Ventilation and Filtration Control

    Rochester, MN

  4. A Study to Evaluate the Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer

    Jacksonville, FL, Rochester, MN

  6. A Study to Evaluate the Safety and Effectiveness of NX9 for CT Imaging in Patients with Cancer or GI Disease

    Rochester, MN

  7. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC

  8. A Study to Evaluate NPC-21 to Treat Kidney Transplant Patients at High Risk for Cytomegalorvirus Infection

    Scottsdale/Phoenix, AZ

  9. Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

    Rochester, MN

  10. Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer